To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.


Already Have an Account?

Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Vol:228 Issue:1 Number:1 ISSN#:2564-2537
ACE Report #14520
Ace Report Cover Shoulder & Elbow

Ketorolac vs. Depomedrol Injections for Subacromial Impingement

How to Cite

OrthoEvidence. Ketorolac vs. Depomedrol Injections for Subacromial Impingement. ACE Report. 2022;228(1):1. Available from:

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Outcomes of ketorolac versus depomedrol infiltrations for subacromial impingement syndrome: a randomized controlled trial

Musculoskelet Surg . 2022 Mar;106(1):29-34.

Contributing Authors:
T Goyal S Paul SS Sethy AK Choudhury

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Seventy patients with subacromial impingement syndrome were randomized to receive a subacromial depomedrol injection (n=35) or a subacromial ketorolac injection (n=35). The outcomes of interest included pain, function and range of motion at one and three month follow-up. There was no significant differences in pain as measured by a visual analogue scale. No differences in function between the two ...

Ace Report Preview Image
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.